YCLIC HEMATOPOIESIS is a rare disorder in humans and grey collie dogs characterized by regular cyclical oscillations in blood counts and periodic severe neutropenia frequently complicated by bacterial infection^."^ Although the mechanisms underlying this disorder are unknown, recent clinical trials have shown that supraphysiologic doses of granulocyte colony-stimulating factor (G-CSF) ameliorate neutropenia in humans and eliminate cyclical hematopoiesis in dogs with this disorder.""* Abnormal responsiveness to G-CSF may be an important pathophysiologic mechanism underlying congenital cyclic hematopoiesis. We previously reported that abnormally increased concentrations in vitro of G-CSF and granulocytemacrophage-CSF (GM-CSF) but not interleukin-3 (IL-3) were required to stimulate maximal granulocytic colony formation by bone marrow (BM) cell populations from patients with congenital cyclic ne~tr0penia.l~ The requirement for increased concentrations of growth factor could be demonstrated at the level of CD34' BM progenitor cells and was most striking with G-CSF. These studies suggest that the abnormality causing cyclic hematopoiesis in humans with cyclic neutropenia lies in growth factor receptor binding or in the postreceptor signal transduction system that drives granulocytopoiesis. To investigate this hypothesis in the grey collie model, we examined BM mononuclear cells and neutrophils from grey collie dogs to determine whether G-CSF responsiveness and G-CSF receptor expression were abnormal.
C MATERIALS AND METHODS
Dogs and blood sampling. Grey collie dogs (ages 1 to 4 years) and normal mongrel dogs were housed in American Association for Accreditation of Laboratory Animal Care (AAALAC)-accredited animal care facilities as previously described.'"16 Daily blood counts were performed between 7 AM and 9 AM, including a white blood cell count with differential, hematocrit, reticulocyte, and platelet ies identified a G-CSF binding protein of approximately 120 kD on neutrophils from grey collies, similar in size to that on normal dog neutrophils. No abnormal G-CSF receptor mRNA transcripts were detected in neutrophils from grey collie dogs by Northern blot analysis. Treatment of both normal and grey collie neutrophils with G-CSF rapidly induced tyrosine phosphorylation of an 80-kD protein that behaved like canine c-rei. These results demonstrate that the abnormal responsiveness to G-CSF in canine cyclic hematopoiesis is present in neutrophil precursors and is not associated with demonstrable alterations in the number, binding affinity, or overall size of the G -S F receptor in neutrophils, or with defective tyrosine phosphorylation of p80. These data suggest that cyclic hematopoiesis is caused by a defect in the G-CSF signal transduction pathway at a point distal to G-CSF receptor binding that does not involve the early biochemical events leading to p80 tyrosine phosphorylation. 0 7994 by The American Society of Hematology.
determinations. Blood samples for neutrophil isolations required between 50 and 120 mL and were timed in grey collies to maximize the neutrophil yield.
In vitro colony formation assays. In vitro BM colony formation was used to assess the potential responsiveness of canine marrow cells to G-CSF. Assays were performed as previously de~cribed'~,'~ using normal and grey collie BM. BM was aspirated into heparin, diluted, and subjected to Ficoll-Paque (Pharmacia, Piscataway, NJ) density gradient centrifugation. To reduce background growth factor production by cells in the marrow, two cycles of adherence to the surface of plastic flasks (T-75; Falcon, Lincoln Park, NJ) for 1 hour at 37°C were performed. The mononuclear cells were plated at 1 X lo5 cellslmL in the presence of 10% fetal calf serum, 5% normal dog serum, and varying concentrations of exogenous G-CSF. Recombinant human and canine G-CSF (rhG-CSF and rcG-CSF) were kindly provided by Dr Lawrence Souza (Amgen, Thousand Oaks, CA). Colonies (greater than 50 cells) were counted at 8 to 10 days ("total colonies"). As a positive control, phytohemagglutinin-stimulated canine leukocyte conditioned medium (PHA-LCM) was routinely assayed as an estimate of maximal colony-forming capacity for each marrow specimen. Data are presented as percent of maximal colony formation."
Isolation of neutrophils. Neutrophils were isolated from heparinized peripheral blood by ficoll-hypaque gradient centrifugation followed by sedimentation in 3% dextran sulfate as previously described.I7 Cells (95% to 98% neutrophils) were washed once with phosphate-buffered saline (PBS) then resuspended in binding buffer consisting of Iscove's modified Dulbecco's medium (IMDM) containing 25 mmol/L HEPES and 4 mg/mL bovine serum albumin (BSA), with the pH adjusted to 7.4.
Iodination of rhG-CSF. All receptor binding studies were performed with rhG-CSF. Five micrograms of the rhG-CSF analogue Met-Lys-rhG-CSF (kindly provided by L. Souza and T. Boone, Amgen) was radioactively labeled using lactoperoxidase, glucose oxidase, and 1 mCi NaI (Amersham, Arlington Heights, IL) as previously described." The '*'I-labeled G-CSF was purified by G-50 sephadex gel filtration. This procedure resulted in specific radioactivities for '"I-G-CSF ranging from 1.7 to 4.6 X IO5 cpm/ng as determined by self-displacement analyses.'7 G-CSF binding assay. Neutrophils (2.0 to 5.0 X 10' ) were incubated for 3 hours at 4°C in binding buffer containing varying concentrations of "'I-G-CSF in the range of 0.01 to I O nmol/L in the presence or absence of a 100-fold excess of unlabeled G-CSF in a final volume of 400 pL. After incubation, the cells were resuspended, transferred onto a 0.75-mL ice-cold mixture of 75% calf serum in binding buffer and then centrifuged. The supernatants were aspirated and the cell pellets were counted in a gamma counter. All binding experiments were performed using duplicate incubations. Specific binding was defined as the amount of binding competed by a 100-fold excess of unlabeled G-CSF. Equilibrium binding data were analyzed according to the method of Scatchard" and by weighted nonlinear least-squares curve fitting as described by Munson and Rodhard." Objective statistical criteria (F test, extra-sum squares principle) were used to evaluate goodness of fit and for discriminating between models." Afiniry labeling and immunoprecipitation of '*'I-G-CSF ligand receptor complexes from dog neutrophils. A total of 5 X 10' neutrophils in 1.0 mL binding buffer was incubated for 3 hours at 4°C with 500 pmol/L '*'I-G-CSF in the presence or absence of a 100-fold excess of unlabeled G-CSF. The cells were washed twice with ice-cold PBS and resuspended in 1 .O mL cold PBS, pH 8.3, to which disuccinimidyl suberate (DSS) was added at a final concentration of 1 mmollL. The reaction was quenched after 30 minutes by the addition of 100 mmoVL Tris-HC1, pH 7.4, and the samples were washed twice with cold PBS. To reduce background nonspecific binding and uncross-linked '*'I-G-CSF, the pellets were resuspended in 70 mmol/L sodium acetate and 50 mmol/L NaCl, pH 4.0, for 10 minutes at 0°C. The samples were washed twice with cold PBS and gently rocked for 20 minutes at 4°C in 1.0 mL lysis buffer consisting of PBS with 1% Triton, 2 mmol/L phenylmethylsulfonyl fluoride (PMSF; Sigma, St Louis, MO), 10 pmol/L pepstatin (Sigma), 1 mg/mL aprotinin (Sigma), 2 mmollL EDTA, 10 p m o E leupeptin (Sigma), and 1 mmol/L diisopropyl-fluorophosphate (DFP; Sigma). The supernatants from spun samples were incubated overnight at 4°C with 30 pL of rabbit antihuman G-CSF antisera that was generated in our laboratory, then 12 hours later incubated with 10% washed staphylococcal A protein (Pansorbin; Calbiochem, La Jolla, CA) for 4 hours at 4°C. The spun samples were washed three times in lysis buffer and then resuspended in sodium dodecyl sulfate (SDS) sample buffer containing 5% 2-mercaptoethanol. Aliquots of the supernatants were applied to a 7.5% SDS-polyacrylamide gel. The dried gel was autoradiographed for 2 weeks at -70°C with an intensifying screen.
Isolation of RNA and Northern analysis. Total RNA was isolated by acid guanidinium thiocyanate-phenol-chloroform extraction."' Ten-microgram total cellular RNA samples were fractionated by electrophoresis through a 1% agarose formaldehyde gel, transferred to nylon membranes, and hybridized to a minimum of 10' cpm/mL "P-labeled probe for the human G-CSF receptor. A probe for the human G-CSF receptor was prepared by Xba I digestion of the 2.5-kb Bgl 2 bounded insert of the human G-CSF receptor cDNA clone D7*' (kindly provided by Alf Larsen, Immunex, Seattle, WA) ligated into the Bam site of pBluescript I1 Sk and labeled with [CU-~*P] dATP by random oligonucleotide priming. The filters were hybridized at 42°C for 16 hours, washed to a final stringency of 0.25X SSC, and exposed to Kodak X-Omat films (Eastman Kodak, Rochester, NY).
Immunoblnting of cell lysates. Neutrophils were isolated as described above after which the cell pellet was washed twice with Hanks' Balanced Salt Solution (GIBCO, Grand Island, NY). Red blood cells were lysed by incubation for 30 minutes at 4°C in ammonium chloride (8.29 g/L, pH 7.27). The neutrophil pellet was resuspended in RPM1 1640 (GIBCO) containing 0.5% BSA (fraction V: Sigma) at 5 X 10' cellslml. Neutrophils were pretreated with 1 mmol/L DFP for 30 minutes at 4°C to inhibit proteases before C-CSF stimulation. Cells were then warmed to 37°C and treated with varying concentrations of G-CSF from 0.01 to 10 ng/mL for 15 minutes. After stimulation, cells were washed in PBS and lysed in lysis buffer (20 mmoVL Tris-HCI, pH 8.0, 150 mmol/L NaCI, IO% glycerol, 1% NP-40), containing 1 mmol/L PMSF, 0.15 U/mL aprotinin, IO pg/mL leupeptin, and 1 mmoVL sodium orthovanadate (Sigma) at 4 T for 20 minutes at a concentration of 10' cells/mL. Insoluble material was removed by centrifugation at 4°C for IO minutes at 10,000g. Whole cell lysates (5 X 10' cells) were mixed I : l with 2X SDS sample buffer containing 2-mercaptoethanol and heated at 95°C for 3 minutes before one-dimensional SDS-polyacrylamide gel electrophoresis (SDS-PAGE) with 7.5% polyacrylamide. After electrophoresis, proteins were electrophoretically transferred to 0.2 p nitrocellulose (Schleicher & Schuell, Keene, NH) in a buffer containing 25 mmol/L Tris, 192 mmoVL glycine, and 20% methanol at 0.4 Amp for 4 hours at 4°C. Residual binding sites were blocked by incubation in TBS (10 mmoVL Tris, pH 8.0, 150 mmol/L NaCI) containing 2% gelatin for 60 minutes at 25°C. The blots were incuhated overnight at room temperature with the antiphosphotyrosine antibody 4G10 (1.5 pg/mL) in TBST (TBS with 0.05% Tween 20). The 4GI0 antibody was generated using phosphotyramine as the immunogen and antibody reactions were detected as described."." Prestained molecular weight markers (BRL, Gaithersburg, MD) were also loaded onto the gel. , Fig 2B) . G-CSF receptor expression was also analyzed in one grey collie dog before and during treatment with rcG-CSF. Before initiation of G-CSF therapy, the number of G-CSF receptors on neutrophils from this dog was 85 per cell and, on a repeat determination 18 months later while on G-CSF, 86 per cell (data not shown).
RESULTS

In
Cross-linking studies. Experiments were performed to determine the size of the G-CSF binding proteins on neutrophils from normal and grey collie dogs. As shown in Fig 3, when neutrophils from normal dogs and grey collies were incubated with '251-labeled G-CSF, then covalently crosslinked with DSS, immunoprecipitated with polyclonal anti-G-CSF antibody, and analyzed by SDS-PAGE under reducing conditions, an identical major labeled band with a molecular weight of 139 kD was observed (see arrow). This band was completely abolished on both normal and grey collie neutrophils when a 100-fold excess of unlabeled G-CSF was present during the incubation. Because the molecular weight of G-CSF is 19 k D , the calculated molecular weight of the G-CSF binding protein on normal and grey collie neutrophils is approximately 120 M). Similar results were obtained and confirmed by densitometry using BM mononuclear cells from normal and grey collie dogs (data not shown).
Northern analysis. G-CSF receptor expression in normal and grey collie cells was also examined by Northern blot analysis. As shown in For For personal use only. on July 15, 2017. by guest www.bloodjournal.org From of G-CSF are required to stimulate in vitro granulocytic colony formation by BM progenitor ~e1ls.l~ On the basis of these observations, a defect in G-CSF signal transduction andor receptor expression has been implicated in the pathogenesis of cyclic hematopoiesis. In the present study, we characterized the responsiveness of neutrophil precursors to G-CSF in vitro and G-CSF receptor expression on mature neutrophils to determine whether they are abnormal in the model disorder in grey collies.
BM mononuclear cells from grey collies required abnormally high concentrations of G-CSF in vitro to achieve halfmaximal colony growth compared with cells from normal dogs. This finding in vitro as well as our previous observations" in vivo that pharmacologic but not physiologic doses of G-CSF eliminated cyclic oscillations in blood counts in grey collies suggested to us that grey collies might express reduced numbers of G-CSF receptors or receptors with an altered affinity for G-CSF. We therefore examined binding of IzI-labeled G-CSF to neutrophils from grey collies and normal dogs. Scatchard analyses of the equilibrium binding data were consistent with expression of a single class of high-affinity receptors on both normal and grey collie cells with similar receptor numbers and binding affinities. No variation in receptor numbers or affinity was observed in the one dog studied during G-CSF treatment. The number and affinity of G-CSF receptors on canine neutrophils is similar to that previously reported for human neutrophils.'7.26-28
In this study, we also characterized the protein that binds G-CSF on grey collie neutrophils. A binding protein of approximately 120 kD was identified on neutrophils from both normal and grey collie dogs. No abnormal G-CSF receptor mRNA transcripts were detected in grey collie neutrophils by Northern analysis. These structural data suggested no large defect in the G-CSF receptor itself.
Recently, Druker et a129 reported rapid tyrosine phosphorylation of p80+"' in human neutrophils treated with G-CSF. Because this is one of the first biochemical events in the signal transduction pathway activated in neutrophils after G-CSF stimulation, we investigated the patterns of protein phosphorylation in normal and grey collie neutrophils after treatment with G-CSF to determine whether G-CSF receptor function in signal transduction is defective in grey collie cells. A similar dose-response to G-CSF was observed. G-CSF rapidly induced prominent tyrosine phosphorylation of an 80-kD protein, suggesting that this part of the pathway in G-CSF-mediated signal transduction is intact in grey collie cells.
The data presented here complement the previous observations by Kyas et al, 24 who reported normal numbers of G-CSF binding sites on neutrophils from humans with cyclic neutropenia. In their study, no information was provided on the size of the receptor protein or size of the mRNA transcripts of G-CSF receptors. In the present study, using the canine model, we show that the abnormal response to G-CSF in cyclic hematopoiesis is not caused by alterations in the number or binding affinity of the G-CSF receptor expressed on neutrophils. However, it is possible that G-CSF receptor expression on neutrophils differs from receptor expression on precursor cells and that the level of expression or properties of the G-CSF receptor on grey collie precursor cells are abnormal. Also, the size of the G-CSF receptor protein and mRNA transcripts are not demonstrably altered in cyclic hematopoiesis. We cannot exclude the possibility of a small deletion or point mutation in the G-CSF receptor, or expression of different G-CSF receptor molecules arising from alternative splicing mechanisms, which would not be detected by the methods used in our studies. Detection of such a defect would require sequence data on the G-CSF receptor gene in grey collie dogs. However, a sensitive functional assay of the receptor shows that one of the early signal transduction pathways activated by G-CSF is clearly intact in grey collie cells.
Taken together, our results show that the abnormal responsiveness to G-CSF in canine cyclic hematopoiesis is not caused by gross alterations in the number, binding affinity, or size of the neutrophil G-CSF receptor, or by abnormal tyrosine phosphorylation of an 80-kD protein that behaves like canine c-rel. These data suggest that the underlying defect in cyclic hematopoiesis is in the G-CSF signal transduction pathway at a point distal to the G-CSF receptor.
